These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 36912585)

  • 21. Recent advances in antifungal chemotherapy.
    Petrikkos G; Skiada A
    Int J Antimicrob Agents; 2007 Aug; 30(2):108-17. PubMed ID: 17524625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pulmonary aspergillosis: a clinical update.
    Zmeili OS; Soubani AO
    QJM; 2007 Jun; 100(6):317-34. PubMed ID: 17525130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cerebral aspergillosis in an HIV-infected patient: unsuccessful outcome despite combined antifungal therapy. ].
    Gasch O; Fernández N; Ayats J; Santin M
    Enferm Infecc Microbiol Clin; 2009 Mar; 27(3):193-4. PubMed ID: 19306722
    [No Abstract]   [Full Text] [Related]  

  • 24. Combination antifungal therapy for invasive fungal infections in children and adults.
    Hatipoglu N; Hatipoglu H
    Expert Rev Anti Infect Ther; 2013 May; 11(5):523-35. PubMed ID: 23627858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic and toxicologic studies in a murine model of invasive pulmonary aspergillosis.
    Clemons KV; Schwartz JA; Stevens DA
    Med Mycol; 2011 Nov; 49(8):834-47. PubMed ID: 21539507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Progress in combination therapy for invasive aspergillosis].
    Luo L; Tong Z
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jan; 37(1):41-4. PubMed ID: 24694973
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of the efficacy of a posaconazole and anidulafungin combination in a murine model of pulmonary aspergillosis due to infection with Aspergillus fumigatus.
    Bedin Denardi L; Pantella Kunz de Jesus F; Keller JT; Weiblen C; de Azevedo MI; Oliveira V; Morais Santurio J; Hartz Alves S
    Diagn Microbiol Infect Dis; 2018 Jan; 90(1):40-43. PubMed ID: 29126660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pulmonary aspergillosis: clinical presentation, diagnostic tests, management and complications.
    Sherif R; Segal BH
    Curr Opin Pulm Med; 2010 May; 16(3):242-50. PubMed ID: 20375786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of voriconazole in the treatment of chronic pulmonary aspergillosis: experience in Japan.
    Saito T; Fujiuchi S; Tao Y; Sasaki Y; Ogawa K; Suzuki K; Tada A; Kuba M; Kato T; Kawabata M; Kurashima A; Sakatani M;
    Infection; 2012 Dec; 40(6):661-7. PubMed ID: 22956473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current and future therapeutic options in the management of invasive aspergillosis.
    Krishnan-Natesan S; Chandrasekar PH
    Drugs; 2008; 68(3):265-82. PubMed ID: 18257606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salvage combination antifungal therapy for acute invasive aspergillosis may improve outcomes: a systematic review and meta-analysis.
    Panackal AA; Parisini E; Proschan M
    Int J Infect Dis; 2014 Nov; 28():80-94. PubMed ID: 25240416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of efficacy of antifungals against Aspergillus fumigatus: value of real-time bioluminescence imaging.
    Galiger C; Brock M; Jouvion G; Savers A; Parlato M; Ibrahim-Granet O
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3046-59. PubMed ID: 23587947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Azole Resistance in Aspergillus fumigatus in Patients with Cystic Fibrosis: A Matter of Concern?
    Hamprecht A; Morio F; Bader O; Le Pape P; Steinmann J; Dannaoui E
    Mycopathologia; 2018 Feb; 183(1):151-160. PubMed ID: 28653258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [symbol: see text]Caspofungin and [symbol: see text]voriconazole for fungal infections.
    Drug Ther Bull; 2004 Jan; 42(1):5-8. PubMed ID: 14768298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful Treatment of Chronic Pulmonary Aspergillosis With Isavuconazole.
    Guillen Vera D; Ruiz Ruigómez M; García Moguel I; Morales Ruiz R; Corbella L; Fernández Rodríguez C
    J Investig Allergol Clin Immunol; 2019; 29(6):459-460. PubMed ID: 31172952
    [No Abstract]   [Full Text] [Related]  

  • 36. Newer triazole antifungal agents: pharmacology, spectrum, clinical efficacy and limitations.
    Aperis G; Mylonakis E
    Expert Opin Investig Drugs; 2006 Jun; 15(6):579-602. PubMed ID: 16732713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Invasive pulmonary aspergillosis after liver transplantation: rapid and complete response to combined and sequential antifungal therapy.
    Can MF; Yagci G; Gorenek L; Tozkoparan E; Ozerhan I; Cetiner S
    Surg Infect (Larchmt); 2008 Feb; 9(1):99-104. PubMed ID: 18363474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful treatment with voriconazole of invasive aspergillosis in chronic granulomatous disease.
    van 't Hek LG; Verweij PE; Weemaes CM; van Dalen R; Yntema JB; Meis JF
    Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1694-6. PubMed ID: 9603157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of current drug therapies for invasive aspergillosis.
    Traunmüller F; Popovic M; Konz KH; Smolle-Jüttner FM; Joukhadar C
    Pharmacology; 2011; 88(3-4):213-24. PubMed ID: 21986253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Update on echinocandin antifungals.
    Kauffman CA; Carver PL
    Semin Respir Crit Care Med; 2008 Apr; 29(2):211-9. PubMed ID: 18366002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.